Literature DB >> 30009949

Porphyrins and related macrocycles: Combining photosensitization with radio- or optical-imaging for next generation theranostic agents.

Jordon Sandland1, Nela Malatesti2, Ross Boyle3.   

Abstract

This review summarises recent research into combining the photosensitizing properties of porphyrins with imaging techniques such as PET and NIR fluorescence for so called "theranostic" applications, which combine biomedical imaging and therapeutic potential into a single administered substance. The photophysical mechanisms of both the therapeutic and diagnostic properties of porphyrins are discussed, as well as key characteristics that are required in order to deliver the most effective treatment.
Copyright © 2018. Published by Elsevier B.V.

Keywords:  Luminescence; PET; Personalized medicine; Photodynamic therapy; Photosensitiser; Theranostics

Mesh:

Substances:

Year:  2018        PMID: 30009949     DOI: 10.1016/j.pdpdt.2018.06.023

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  2 in total

Review 1.  Porphyrins as Chelating Agents for Molecular Imaging in Nuclear Medicine.

Authors:  Krystyna Pyrzynska; Krzysztof Kilian; Mateusz Pęgier
Journal:  Molecules       Date:  2022-05-21       Impact factor: 4.927

2.  Encapsulation of Hydrophobic Porphyrins into Biocompatible Nanoparticles: An Easy Way to Benefit of Their Two-Photon Phototherapeutic Effect without Hydrophilic Functionalization.

Authors:  Limiao Shi; Christophe Nguyen; Morgane Daurat; Nicolas Richy; Corentin Gauthier; Estelle Rebecq; Magali Gary-Bobo; Sandrine Cammas-Marion; Olivier Mongin; Christine O Paul-Roth; Frédéric Paul
Journal:  Cancers (Basel)       Date:  2022-05-10       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.